GRM2 and schizophrenia: The best working pair of compounds with evident efficacy in models of the positive, negative, and cognitive symptoms of schizophrenia were ligands that activated mGlu4/M4 receptors and mGlu2/M4 receptors (although these drugs were not tested in the models of positive symptoms) [152,239].